I agree that this site is using cookies. You can find further informations here.
X
Duhaze, Julianne
43  results:
Search for persons X
?
1

Clinicogenomic factors of biotherapy immunogenicity in auto..:

Hässler, Signe ; Bachelet, Delphine ; Duhaze, Julianne...
PLOS Medicine.  17 (2020)  10 - p. e1003348 , 2020
Link: https://doi.org/10.1371/..
 
?
2

A Machine Learning Approach for High-Dimensional Time-to-Ev..:

Duhazé, Julianne ; Hässler, Signe ; Bachelet, Delphine...
Frontiers in Immunology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
3

Quantifying the Predictive Accuracy of a Polygenic Risk Sco..:

Duhazé, Julianne ; Jantzen, Rodolphe ; Payette, Yves...
Frontiers in Genetics.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
4

Assessing the effect of genetic markers on drug immunogenic..:

on behalf of the ABIRISK Consortium ; Duhazé, Julianne ; Caubet, Miguel...
BMC Medical Research Methodology.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

Assessing the effect of genetic markers on drug immunogenic..:

Duhazé, Julianne ; Caubet, Miguel ; Hässler, Signe...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082907/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
6

Assessing the effect of genetic markers on drug immunogenic..:

Duhazé, Julianne ; Caubet, Miguel ; Hässler, Signe...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12874-020-00941-z.  , 2020
Link: https://hal.sorbonne-uni..
 
?
7

Clinicogenomic factors of biotherapy immunogenicity in auto..:

Hässler, Signe ; Bachelet, Delphine ; Duhaze, Julianne...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pmed.1003348.  , 2020
Link: https://hal.sorbonne-uni..
 
?
8

A Machine Learning Approach for High-Dimensional Time-to-Ev..:

Duhazé, Julianne ; Hässler, Signe ; Bachelet, Delphine...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2020.00608.  , 2020
Link: https://hal.sorbonne-uni..
 
?
9

A Machine Learning Approach for High-Dimensional Time-to-Ev..:

Duhazé, Julianne ; Hässler, Signe ; Bachelet, Delphine...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2020.00608.  , 2020
Link: https://hal.sorbonne-uni..
 
?
10

Assessing the effect of genetic markers on drug immunogenic..:

Duhazé, Julianne ; Caubet, Miguel ; Hässler, Signe...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12874-020-00941-z.  , 2020
Link: https://hal.sorbonne-uni..
 
?
11

Clinicogenomic factors of biotherapy immunogenicity in auto..:

Hässler, Signe ; Bachelet, Delphine ; Duhaze, Julianne...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pmed.1003348.  , 2020
Link: https://hal.sorbonne-uni..
 
?
12

A Machine Learning Approach for High-Dimensional Time-to-Ev..:

Duhazé, Julianne ; Hässler, Signe ; Bachelet, Delphine...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2020.00608.  , 2020
Link: https://hal.sorbonne-uni..
 
?
13

Assessing the effect of genetic markers on drug immunogenic..:

Duhazé, Julianne ; Caubet, Miguel ; Hässler, Signe...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12874-020-00941-z.  , 2020
Link: https://hal.sorbonne-uni..
 
?
14

A Machine Learning Approach for High-Dimensional Time-to-Ev..:

Duhazé, Julianne ; Hässler, Signe ; Bachelet, Delphine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154163/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

A Machine Learning Approach for High-Dimensional Time-to-Ev..:

Duhazé, Julianne ; Hässler, Signe ; Bachelet, Delphine...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2020.00608.  , 2020
Link: https://hal.sorbonne-uni..
 
1-15